Facebook
Twitter
LinkedIn
ForwardHow to Optimally Deliver Vaginal Cuff Brachytherapy for Endometrial Cancer in Your Practice: Tips and Tricks From the Experts
Vaginal cuff brachytherapy (VBT) is a critical part of a radiation oncologist's practice and is routinely offered both at academic sites and within the community. However, in the modern era, many are stretched increasingly thin and have fewer resources to work with. This series consists of two parts: 1) how to appropriately make recommendations for VBT for endometrial cancer and 2) efficiently deliver high-quality VBT in one's practice. Following this series, learners will effectively be able to implement a successful VBT at their program.
TOPICS COVERED:
Each topic is available as an onDemand recording.
- Practical Aspects of Vaginal Brachytherapy for Endometrial Cancer
- New Trials and Future Directions in Endometrial Cancer and Vaginal Cuff Brachytherapy
Please see the Program tab for session descriptions and presenters.
This activity is available from July 29, 2024 through 11:59 p.m. Eastern time on September 10, 2026.
The content was originally presented and recorded as a live webinar series on September 4 and September 11, 2024.
Target Audience
This activity is designed to meet the interests of radiation oncologists, medical oncologists, and radiation oncology residents.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Define who are (and who are not) appropriate candidates for VBT.
- Implement a successful VBT within their program.
- Better understand how to approach endometrial cancer cases in their clinical practice.
- Recognize the underutilization of brachytherapy.
- Discuss treatment disparities and access to patients.
- Identify challenges faced in light of new immunotherapy clinical trials.
- Incorporate adjuvant radiation therapy into current practice in the context of new clinical data.
- Understand the practical and technical aspects of vaginal brachytherapy.
- Articulate the molecular factors influencing how we care for endometrial cancer patients.
New Trials and Future Directions in Endometrial Cancer and Vaginal Cuff Brachytherapy
— Idalid Ivy Franco, MD, MPH; Matthew Harkenrider, MD
This activity reviews 1) the guidelines and standards of care for the adjuvant management of endometrial cancer with an emphasis on vaginal brachytherapy 2) how to incorporate adjuvant radiation therapy into current practice in the context of new clinical data 3) practical treatment approaches and technical aspects of vaginal brachytherapy 4) access to care for endometrial cancer patients and 5) the molecular factors influencing how we care for endometrial cancer patients. Difficult cases are presented and attendees have the opportunity to ask questions of panelists to better understand how to approach such cases in their own clinical practice.
Practical Aspects of Vaginal Brachytherapy for Endometrial Cancer
— Lara Hathout, MD, FRCPC; Matthew Harkenrider, MD
In this activity we review the practical aspects of VBT planning including choice of applicators, dose, prescription and planning. We include and discuss cases and provide tips to build a brachytherapy program. In addition, we highlight the underutilization of brachytherapy, disparity in treatment and access to patients. Finally, we discuss the challenges being faced in light of new immunotherapy clinical trials.
- Lara Hathout, MD, FRCPC, is employed by Rutgers Cancer Institute of New Jersey. Dr. Hathout receives compensation as a consultant from the RTOG Foundation.
- Matthew Harkenrider, MD, is employed by Loyola University Medical Center. Dr. Harkenrider receives compensation as a consultant from the RTOG Foundation and from NEED.
- Parul Barry, MD, is employed by UPMC Radiation Oncology. Dr. Barry receives honoraria and travel expenses from Elsevier Pathways, ASTRO and ACRO. Dr. Barry is a member of the ACRO Board of Chancellors; Chair of Education for the HEDI Council with ASTRO; Director of Research and Scientific Program for the Women in Medicine Summit; Senior Associate Editor of the Journal on Rare Tumors; and a Senior Advisory Committee member with SWRO.
- Idalid Ivy Franco, MD, MPH, is employed by Brigham and Women's Hospital/Dana-Farber Cancer Institute. Dr. Franco receives grant/research funding from the National Cancer Institute, NIH/NCI, Brigham and Women's Hospital/Dana-Farber Cancer Institute and ASTRO/RTOG NRG Oncology Health Equity Fellowship. Dr. Franco is Executive Vice Chair of the Equity and Inclusion Subcommittee for ARRO and serves as Vice Chair of the Health Equity Education Committee for the Council on Health Equity Diversity and Inclusion with ASTRO.
All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 3.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.00 Certificate of AttendanceThis activity was designated for 3.00 AMA PRA Category 1 Credit™.
Price
Course fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
Member: $199
Member-in-training: $99
Member Student/Grad Student/PGY: $99
Member Postdoctoral Fellow: $99
Nonmember: $299
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until September 10, 2026, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.